pilot study [Design Issues]

posted by ioanam – Romania, 2006-12-22 10:29 (7128 d 10:53 ago) – Posting: # 414
Views: 7,081

Dear Sir,
I have to perform a 3 way cross over pilot study.
The test product is available in 4 strengths (e.q. 250, 500, 750 and 1000 mg) with dose proportionality between these strengths. The pharmacokinetics is not influenced by food.
Is a good design for this study a 3 way crossover study in fasted conditions with 3 sequences, 3 treatments and 3 periods with:
Test A – test product 4 x 250 mg
Test B – test product 1000 mg
Reference – reference (1000 mg)?
Thank you
and Marry Christmas!

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
339 visitors (0 registered, 339 guests [including 8 identified bots]).
Forum time: 22:23 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5